A Prospective, Open-Label Pilot Study of Concurrent Male Partner Treatment for Bacterial Vaginosis
Recurrence of BV following standard treatment is unacceptably high. Posttreatment recurrence is distressing for women, and it imposes a considerable burden on the health care system.
Main Authors: | Erica L. Plummer, Lenka A. Vodstrcil, Michelle Doyle, Jennifer A. Danielewski, Gerald L. Murray, Glenda Fehler, Christopher K. Fairley, Dieter M. Bulach, Suzanne M. Garland, Eric P. F. Chow, Jane S. Hocking, Catriona S. Bradshaw |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2021-10-01
|
Series: | mBio |
Online Access: | https://journals.asm.org/doi/10.1128/mBio.02323-21 |
Similar Items
-
Bacterial vaginosis: drivers of recurrence and challenges and opportunities in partner treatment
by: Lenka A. Vodstrcil, et al.
Published: (2021-09-01) -
Efficacy of oral metronidazole with vaginal clindamycin or vaginal probiotic for bacterial vaginosis: randomised placebo-controlled double-blind trial.
by: Catriona S Bradshaw, et al.
Published: (2012-01-01) -
Lactic acid-containing products for bacterial vaginosis and their impact on the vaginal microbiota: A systematic review.
by: Erica L Plummer, et al.
Published: (2021-01-01) -
Hormonal contraception is associated with a reduced risk of bacterial vaginosis: a systematic review and meta-analysis.
by: Lenka A Vodstrcil, et al.
Published: (2013-01-01) -
Factors Associated with Bacterial Vaginosis among Women Who Have Sex with Women: A Systematic Review.
by: Dana S Forcey, et al.
Published: (2015-01-01)